FDA fast-tracked bespoke infant gene therapy in six weeks
Jessica Lessin · What Tim Cook’s “Executive Chairman” Move Really Means | Musk vs OpenAI, xAI and Cursor Rumors · Apr 24, 2026 · at 5:14
Jessica Lessin, founder and CEO of The Information, recounts a case presented at the Breakthrough Prize where scientists developed a bespoke therapy for an infant.
“Baby KJ was a baby who Add, I think it was a liver disorder or just, you know, at birth was identified with something that, that really was a horrible, horrible prognosis. And two scientists fast tracked with the FDA, like a one of one drug. So a drug that was like totally targeted to KJ's condition. And basically cured it. And it's an amazing story too, because like the FDA did the approval in like six weeks or something incredible.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →